Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

US Patent 10227591 · Granted Mar 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting cell tropism receptors to inhibit cytomegalovirus infection2025
Methods for preventing graft ischemia reperfusion injury during ex vivo machine 2024
Therapeutic alteration of transplantable tissues through In Situ or Ex Vivo expo2024
Targeting cell tropism receptors to inhibit cytomegalovirus infection2022
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2022
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2019
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro2017
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro2017
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro2017
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2015
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2015
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro2015